Xerox Phaser 6250 - Инструкция по эксплуатации - Страница 196

Цветной лазерный принтер Phaser® 6250

E-5

Additional Information

: The results obtained from a Xerox sponsored Chronic Toner 

Inhalation Study demonstrated no lung changes in rats for the lowest (1 mg/m

3

) 

exposure level (i.e., the level most relevant to potential human exposure). A very slight 
degree of fibrosis was noted in 25% of the animals at the middle (4 mg/m

3

) exposure 

level, while a slight degree of fibrosis was noted in all the animals at the highest (16 mg/
m

3

) exposure level. The findings are attributed to "lung overloading," a generic 

response to excessive amounts of any dust retained in the lungs for a prolonged period. 
This study was conducted using a special test toner to comply with EPA testing 
protocol. The test toner was ten times more respirable than commercially available 
Xerox toner and would not be functionally suitable for Xerox equipment.

Section 12–Ecological Information

Not available

Section 13–Disposal Consideration

These materials are not RCRA hazardous wastes as specified in 40 CFR 261. State and 
local waste disposal requirements, however, may be more restrictive. Dispose in accordance 
with all federal, state, and local regulations. Incinerate only in a closed container.

Section 14–Transport Information

DOT

: Not regulated

Section 15–Regulatory Information

TSCA

: All components of these toners have been manufactured in compliance with 

TSCA.

CANADIAN WHMIS

: These toners are not regulated as controlled products under the 

Workplace Hazardous Material Information System (WHMIS).

Section 16–Other Information

NFPA 704: Health–0, Fire–1, Reactivity–0 (All colors)

Original preparation date: 05/06/2003

Xerox Corporation

Office Group

Environmental, Health & Safety

P.O.  Box  10 0 0

Mail Stop 60-512

Wilsonville, Oregon 97070

Safety Information: 80 0-828-6571

Health Emergency: 585-422-2177

Transportation Emergency (Chemtrec): 80 0-424-930 0